NMRA: Neumora Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 107.69
Enterprise Value ($M) -19.17
Book Value ($M) 228.36
Book Value / Share 1.41
Price / Book 0.47
NCAV ($M) 226.48
NCAV / Share 1.40
Price / NCAV 0.48

Profitability (mra)
Return on Invested Capital (ROIC) -1.13
Return on Assets (ROA) -0.57
Return on Equity (ROE) -0.61

Liquidity (mrq)
Quick Ratio 8.98
Current Ratio 8.98

Balance Sheet (mrq) ($M)
Current Assets 254.87
Assets 256.75
Liabilities 28.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -263.46
Net Income -243.79
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -182.94
Cash from Investing -70.56
Cash from Financing 21.60

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
7 days ago 13G/A Fmr Llc 2.20 -59.45
02-13 13G/A Berns Paul L 5.10 3.03
11-22 13D/A ARCH Venture Fund XII, L.P. 19.80 0.04
11-12 13G Softbank Group Corp 4.70 -1.31

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 419,799 928,921 45.19
2025-05-14 487,096 937,996 51.93
2025-05-13 279,611 899,631 31.08

(click for more detail)

Similar Companies
NBIX – Neurocrine Biosciences, Inc. NEOG – Neogen Corporation
NKTX – Nkarta, Inc. NUVL – Nuvalent, Inc.
NVAX – Novavax, Inc.


Financial data and stock pages provided by
Fintel.io